awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38155855-0B161C26-F6A3-4BAD-8490-6A6C85771C25
Q38155855-0B161C26-F6A3-4BAD-8490-6A6C85771C25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38155855-0B161C26-F6A3-4BAD-8490-6A6C85771C25
The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy era.
P2860
Q38155855-0B161C26-F6A3-4BAD-8490-6A6C85771C25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38155855-0B161C26-F6A3-4BAD-8490-6A6C85771C25
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
275520db3b4985832cc8c4fd7b26cc45d06fca00
P2860
Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.